Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Gerstner Sloan Kettering School of Biomedical Sciences, New York, New York, USA.
Lindsay M
LM
LaFave
Department of Hematology-Oncology, Weill Cornell Medical College, New York, New York, USA.
Wendy
W
Béguelin
The Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Richard
R
Koche
Department of Hematology-Oncology, Weill Cornell Medical College, New York, New York, USA.
Matt
M
Teater
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Barbara
B
Spitzer
The Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Alan
A
Chramiec
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Efthymia
E
Papalexi
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Matthew D
MD
Keller
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Todd
T
Hricik
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Katerina
K
Konstantinoff
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Jean-Baptiste
JB
Micol
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Benjamin
B
Durham
Epizyme, Inc., Cambridge, Massachusetts, USA.
Sarah K
SK
Knutson
Epizyme, Inc., Cambridge, Massachusetts, USA.
John E
JE
Campbell
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.|Tri-Institutional Program in Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Gil
G
Blum
Chemical Synthesis Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Xinxu
X
Shi
Proteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
Emma H
EH
Doud
The Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Andrei V
AV
Krivtsov
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Young Rock
YR
Chung
Anti-Tumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Inna
I
Khodos
Anti-Tumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Elisa
E
de Stanchina
Chemical Synthesis Core, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ouathek
O
Ouerfelli
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Prasad S
PS
Adusumilli
Proteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
Paul M
PM
Thomas
Proteomics Center of Excellence, Northwestern University, Evanston, Illinois, USA.
Neil L
NL
Kelleher
Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
Minkui
M
Luo
Epizyme, Inc., Cambridge, Massachusetts, USA.
Heike
H
Keilhack
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Omar
O
Abdel-Wahab
Department of Hematology-Oncology, Weill Cornell Medical College, New York, New York, USA.
Ari
A
Melnick
The Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Scott A
SA
Armstrong
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|The Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.|Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Ross L
RL
Levine
D006801:Humans; D008545:Melanoma; D025521:Tumor Suppressor Proteins; D043222:Ubiquitin Thiolesterase; D014604:Uveal Neoplasms; D000098943:Uveal Melanoma
D025521:Tumor Suppressor Proteins; D043222:Ubiquitin Thiolesterase